VeriMomVeriMom
HIGH RISK

임신 중 cannabigerol을 피해야 할까요? | VeriMom

No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).

ECHA regulatory hazard statements

  • H361D

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

cannabigerol은 임신 중 안전한가요?
No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
cannabigerol은 모유 수유 중 안전한가요?
There are no authoritative safety assessments (CIR/SCCS/harmonised CLP) specifically identifying CBG as a confirmed reproductive or lactation hazard. Cannabinoids can be transferred to milk (class concern from THC/CBD literature) so a theoretical class-based mechanism exists, but direct studies on CBG transfer in human milk or lactation-specific toxicity are not found; topical cosmetic use would give low but measurable maternal systemic exposure in some scenarios, so breastfeeding exposure is possible but not characterized for CBG.
cannabigerol은 아기 피부에 안전한가요?
No infant-specific toxicity or safety data for topical CBG were identified. By class-based analogy to other cannabinoids there is a theoretical mechanism, but no direct evidence that CBG causes reproductive/infant toxicity. Because infant skin has higher absorption per kg, exposure score is increased by +1 compared with adults when measurable dermal absorption is plausible; direct dermal absorption studies for CBG were not found.
VeriMom은 cannabigerol을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cannabigerol을 27/100 (높은 위험)로 평가합니다.
임신 중 cannabigerol 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요